On September 29 and 30, 2022 the North American femtech community is coming together again in Boston for the 4th edition of Women’s Health Innovation Summit. Each year the 2-day event invites selected startups to pitch their solutions in front of industry leaders and investors. Just recently the finalists, who were selected by 10 leading VCs in the space, were announced. Selection…
Heather Delaney, the Founder and Managing Director of Gallium Ventures, a tech communications consultancy, has been the CES hero we all didn’t know we needed, but got this year. While many of us were back in yet another pandemic lockdown she was out and about and one of the around 40,000 attendees who “defied the odds” and made the trip to Las…
Choir, a diversity-tech platform and certification for finance conferences, launches today to make industry events more representative of the U.S. population. Choir’s proprietary algorithm uses hundreds of data points to assess the prominence and visibility of women, non-binary people and people of color on stages – setting the first industry benchmark for conference diversity, the Choir Certification. Choir then uses this data…
On Friday, December 17th, HITLAB Women’s Health Tech Initiative will host its fourth annual Women’s Health Tech (WHT) Challenge, where 8 promising femtech founders will pitch their solutions to a panel of judges in an effort to discover the next wave of innovation that can address the unmet needs within women’s health. The HITLAB WHT Challenge began in 2018, focusing on emerging technology applications and systems that improve medical care and the provision of healthcare among women worldwide. “The Global market…
Women’s Health startup Hormona has won the Slush 100 Pitching Competition which took place last week at Slush Conference in Helsinki, Finland. Hormona is a young healthtech company helping patients detect patterns in their bodies’ rhythm, learn how to tweak them, and get their hormonal health back on track. The Hormona team launched their first product, a data-driven solution for women to…
In 1977 the Food and Drug Administration (FDA) made a decision to exclude “women of childbearing potential from participation in clinical trials”. The reasoning at the time? Male and female bodies are pretty much the same and hormonal fluctuations during a menstrual cycle would only complicate analysis of any data collected — and increase costs. Plus, the risk of including women of…
Women’s health is a new focal point for investors. More research and more investment dollars are going into solving healthcare challenges that are specific to women such as breast cancer and ovarian cancer, fertility, pregnancy, birthing, and menopause. Some healthcare issues disproportionately affect women like infant care, but others such as heart disease have not had solutions developed which meaningfully consider gender…
Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players including investors and insurers. It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach. The Women’s Health Innovation Summit is the sector’s leading platform committed to strengthening the network, tackling unmet needs and championing innovative approaches and solutions. Our focus…
